Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2021-03-26 Declaration of Voting R…
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This document is an official record of the voting outcomes from the Annual General Meeting, which directly maps to the 'Declaration of Voting Results & Voting Rights Announcements' category.
2021-03-26 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). It contains detailed corporate information, history, management changes, and financial data tables. Since it is a comprehensive annual filing (even though it is a correction to the original), it falls under the Annual Report category. FY 2020
2021-03-26 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (Gencurix) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, the counterparty, the region, and the duration. Since this is a specific regulatory announcement of a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Gencurix. It contains key financial data, audit opinions (적정), and details regarding the audit process as required by regulatory standards. While it provides financial summaries, it is a specific regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full annual report (10-K) or a simple publication notice (RPA). Given the specific nature of audit report filings in the Korean regulatory context, it is classified as an Audit Report (AR). FY 2020
2021-03-18 Korean
사업보고서 (2020.12)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Gencurix, Inc. for the fiscal year ending December 31, 2020. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This constitutes a full annual financial report, which falls under the 'Interim / Quarterly Report' (IR) category in the provided schema, as it contains substantive financial statements and analysis for a specific reporting period. FY 2020
2021-03-18 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This is a standard corporate disclosure form submitted to the Financial Services Commission/Korea Exchange regarding changes in the board of directors. According to the provided definitions, announcements regarding changes in the board of directors or senior management fall under the 'MANG' (Board/Management Information) category.
2021-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.